212 related articles for article (PubMed ID: 36452225)
1. Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials.
Wei J; Ma T; Zhou C; Hao P; Li B; Wang X; Yu R; Zhu M; Wang Y
Front Pharmacol; 2022; 13():1002713. PubMed ID: 36452225
[No Abstract] [Full Text] [Related]
2. Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow.
Guo H; Li X; Zhu M
Front Pharmacol; 2022; 13():955146. PubMed ID: 36071856
[No Abstract] [Full Text] [Related]
3. Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis.
Wang M; Shan Y; Sun W; Han J; Tong H; Fan M; Chen J; Yu P; Shen L; Chen X
Front Pharmacol; 2021; 12():751050. PubMed ID: 34795585
[No Abstract] [Full Text] [Related]
4. Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
Wei J; Liu S; Wang X; Li B; Qiao L; Wang Y; Zhu M
Evid Based Complement Alternat Med; 2021; 2021():2672516. PubMed ID: 34931125
[TBL] [Abstract][Full Text] [Related]
5. A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes: A systematic review.
Zhou Z; Shen W; Yu L; Xu C; Wu Q
J Ethnopharmacol; 2016 Dec; 194():1130-1139. PubMed ID: 27847338
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of Xueshuantong (lyophilized) for injection in the treatment of unstable angina pectoris: A systematic review and meta-analysis.
Xi J; Wei R; Cui X; Liu Y; Xie Y
Front Pharmacol; 2023; 14():1074400. PubMed ID: 37089918
[No Abstract] [Full Text] [Related]
7. Combination of Chinese herbal medicine and conventional western medicine for coronavirus disease 2019: a systematic review and meta-analysis.
Tong L; Ma Z; Zhou Y; Yang S; Yang Y; Luo J; Huang J; Wang F
Front Med (Lausanne); 2023; 10():1175827. PubMed ID: 37529247
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials.
Wei J; Li B; Wang X; Li X; Hu Y; Qiao L; Zhou C; Yu P; Sang T; Zhu M; Wang Y
Front Pharmacol; 2022; 13():893602. PubMed ID: 35571117
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction: A single-center, double-blind, randomized controlled trial.
Yang Y; Gao S; Fang Q; Zhu M
Medicine (Baltimore); 2021 Jan; 100(3):e24246. PubMed ID: 33546045
[TBL] [Abstract][Full Text] [Related]
10. External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis.
Wei X; Wen Y; Wei Y; Liang X; Ma X; Zhang B; Tang X
Front Med (Lausanne); 2022; 9():940328. PubMed ID: 36017012
[TBL] [Abstract][Full Text] [Related]
11. Potential efficacy and safety of Xiyanping injection as adjuvant therapy in treatment of suppurative acute tonsillitis: a meta-analysis, trial sequential analysis, and certainty of evidence.
Cheng FJ; Lyu J; Wang LX; Xie YM
Front Pharmacol; 2024; 15():1327856. PubMed ID: 38933666
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis.
Li L; Feng P; Zhou W; Luo B; Deng L; Gan D; Wu X; Zhu F; Zhou X
Front Cardiovasc Med; 2024; 11():1229299. PubMed ID: 38414926
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of Chinese patent medicines in patients with carotid atherosclerotic plaque: a Bayesian network meta- analysis.
Su W; Xie X; Zhao J; Fan Q; Dong N; Li Q; Du Y; Wu S
Chin Med; 2023 Nov; 18(1):152. PubMed ID: 37986011
[TBL] [Abstract][Full Text] [Related]
14. The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials.
Huang P; Li Z; Chen L; Zeng J; Zhao S; Tang Y; Huang B; Guan H; Chen Y; Feng Y; Lei S; Wu Q; Zhang H; Huang X; Zeng L; Liu Y; Zeng Z; Chen B
Front Pharmacol; 2022; 13():918689. PubMed ID: 36059992
[No Abstract] [Full Text] [Related]
15. Shexiang Baoxin Pill enriches Lactobacillus to regulate purine metabolism in patients with stable coronary artery disease.
Wu G; Liao J; Zhu X; Zhang Y; Lin Y; Zeng Y; Zhao J; Zhang J; Yao T; Shen X; Li H; Hu L; Zhang W
Phytomedicine; 2024 Jul; 130():155727. PubMed ID: 38781732
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis.
Wen J; Ma X; Zhang L; Lu X; Yang Y; Wang J; Zhao Y
Medicine (Baltimore); 2018 Dec; 97(51):e13580. PubMed ID: 30572460
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Chinese herbal medicine in post-stroke epilepsy: a systematic review and meta-analysis.
Sun T; Wang K; Li L; Yan M; Wu J; Liu J
Front Pharmacol; 2023; 14():1286093. PubMed ID: 38074155
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness analysis of Shexiang Baoxin Pill (MUSKARDIA) as the add-on treatment to standard therapy for stable coronary artery disease in China.
Pan J; Ping PD; Wang W; Zhou JM; Zhu WT
PLoS One; 2024; 19(3):e0299236. PubMed ID: 38427636
[TBL] [Abstract][Full Text] [Related]
19. [Meta-analysis and GRADE evaluation of Guanxinning Tablets in treatment of angina pectoris of coronary heart disease].
Li XY; Sun DX; Xu YN; Gao XH; Fan KF
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):247-255. PubMed ID: 36725277
[TBL] [Abstract][Full Text] [Related]
20. Wuhu decoction combined with azithromycin for treatment of
Yang S; Liu X; Wang H; Wang H; Sun D; Han Y; Li H; Li X
Front Pharmacol; 2024; 15():1329516. PubMed ID: 38633618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
